Package 76420-885-21

{"route": ["ORAL"], "spl_id": "2a395a10-4c73-4213-e063-6394a90abb25", "openfda": {"unii": ["B53E3NMY5C"], "rxcui": ["313412", "313413"], "spl_set_id": ["a9ba9023-0c3f-4c9b-ba8e-d39d23bf35d6"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE (76420-885-00)", "package_ndc": "76420-885-00", "marketing_start_date": "20241227"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (76420-885-01)", "package_ndc": "76420-885-01", "marketing_start_date": "20241227"}, {"sample": false, "description": "10 TABLET in 1 BLISTER PACK (76420-885-11)", "package_ndc": "76420-885-11", "marketing_start_date": "20241227"}, {"sample": false, "description": "15 TABLET in 1 BOTTLE (76420-885-15)", "package_ndc": "76420-885-15", "marketing_start_date": "20241227"}, {"sample": false, "description": "150 TABLET in 1 BOTTLE (76420-885-21)", "package_ndc": "76420-885-21", "marketing_start_date": "20241227"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (76420-885-30)", "package_ndc": "76420-885-30", "marketing_start_date": "20241227"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (76420-885-60)", "package_ndc": "76420-885-60", "marketing_start_date": "20241227"}, {"sample": false, "description": "10 TABLET in 1 BOTTLE (76420-885-88)", "package_ndc": "76420-885-88", "marketing_start_date": "20241227"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (76420-885-90)", "package_ndc": "76420-885-90", "marketing_start_date": "20241227"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (76420-885-99)  / 10 TABLET in 1 BLISTER PACK", "package_ndc": "76420-885-99", "marketing_start_date": "20241227"}], "brand_name": "tizanidine", "product_id": "76420-885_2a395a10-4c73-4213-e063-6394a90abb25", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "76420-885", "generic_name": "tizanidine", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "tizanidine", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA208187", "marketing_category": "ANDA", "marketing_start_date": "20210304", "listing_expiration_date": "20261231"}